Jim Mullen
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jim Mullen
Jim Mullen is recorded as CEO at Editas Medicine, Inc. (EDIT). Jim Mullen has spoken on 4 earnings calls across 1 company, most recently for Editas Medicine, Inc. on August 3, 2022.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Editas Medicine, Inc.
Other people whose current roles at this company are on record from its filings.
- Gilmore O'Neill, M.B., M.M.Sc. CEO, Board Member
- James C. Mullen CEO
- Katrine S. Bosley CEO
- Jessica Hopfield Chairman
- Amy Parison CFO
- Andrew A. F. Hack CFO
- Eric Ek CFO
- Erick J. Lucera CFO
- Vic Myer CTO
- Bernadette Connaughton Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.